Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01012089 · ClinicalTrials.gov registry record · NA
Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01012089 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 6 participants.
The verdict
NCT01012089, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1. Study the pharmacokinetics and safety of daptomycin in children on hemodialysis (HD) and peritoneal dialysis (PD). 2. Determine urine, HD and PD clearance of daptomycin.
Interventions
- DRUG Daptomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01012089
The ClinicalTrials.gov registry entry for NCT01012089 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Daptomycin is the first listed.
NCT01012089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01012089 about?
NCT01012089 is a clinical study titled "Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease". The purpose of this study is to: 1. Study the pharmacokinetics and safety of daptomycin in children on hemodialysis (HD) and peritoneal dialysis (PD). 2. Determine urine, HD and PD clearance of daptomycin.
What is the current status of trial NCT01012089?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2009-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01012089?
The interventions under investigation include: Daptomycin (DRUG).
Who is sponsoring clinical trial NCT01012089?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.